Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results
February 23, 2023 06:05 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...
Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference
February 21, 2023 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
January 26, 2023 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will...
Nautilus Biotechnology Expands to San Diego
January 26, 2023 07:45 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)
January 19, 2023 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, and the Translational...
Nautilus Biotechnology Launches “First Access Challenge”
November 16, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology Reports Third Quarter 2022 Financial Results
November 01, 2022 06:05 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...
Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022
October 05, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit
September 23, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board
September 01, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...